Research Progress on the PD-1/PD-L1 Signaling Pathway in Recurrent or Advanced Endometrial Cancer
Endometrial cancer is one of the common malignant tumors in the female reproductive system,posing a serious threat to women's health.Although endometrial cancer generally has a high cure rate,especially when detec-ted and diagnosed early,recurrent or advanced endometrial cancer faces limited treatment options and poor prognosis.Therefore,the search for new treatment strategies becomes extremely important.In recent years,immune therapy has shown promising efficacy and safety in clinical trials for recurrent or advanced endometrial cancer.This article will discuss the latest research progress on the PD-1/PD-L1 signaling pathway in recurrent or advanced endo-metrial cancer,aiming to provide new treatment options and ideas for the clinical management of recurrent or ad-vanced endometrial cancer.
Recurrent or advanced endometrial cancerPD-1/PD-L1 signaling pathwayResearch progress
万方数据
维普
